Literature DB >> 17306975

Practical Bayesian adaptive randomisation in clinical trials.

Peter F Thall1, J Kyle Wathen.   

Abstract

While randomisation is the established method for obtaining scientifically valid treatment comparisons in clinical trials, it sometimes is at odds with what physicians feel is good medical practice. If a physician favours one treatment over another based on personal experience or published data, it may be more appropriate ethically for that physician to use the favoured treatment, rather than enrolling patients on a randomised trial. Still, the randomised trial may later show the physician's favoured treatment to be inferior. This paper reviews a statistical method, Bayesian adaptive randomisation, that provides a practical compromise between the scientific ideal of conventional randomisation and choosing each patient's treatment based on a personal preference that may prove to be incorrect. The method will first be illustrated by a simple hypothetical example, then by a recent trial in which patients with unresectable soft tissue sarcoma were adaptively randomised between two chemotherapy regimens.

Entities:  

Mesh:

Year:  2007        PMID: 17306975      PMCID: PMC2030491          DOI: 10.1016/j.ejca.2007.01.006

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  16 in total

1.  Equipoise, knowledge and ethics in clinical research and practice.

Authors:  Richard Ashcroft
Journal:  Bioethics       Date:  1999-07       Impact factor: 1.898

2.  New designs for phase 2 clinical trials.

Authors:  Elihu H Estey; Peter F Thall
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

3.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

4.  The randomization and stratification of patients to clinical trials.

Authors:  M Zelen
Journal:  J Chronic Dis       Date:  1974-09

Review 5.  Adjustments for center in multicenter studies: an overview.

Authors:  A R Localio; J A Berlin; T R Ten Have; S E Kimmel
Journal:  Ann Intern Med       Date:  2001-07-17       Impact factor: 25.391

6.  Continuous Bayesian adaptive randomization based on event times with covariates.

Authors:  Ying Kuen Cheung; Lurdes Y T Inoue; J Kyle Wathen; Peter F Thall
Journal:  Stat Med       Date:  2006-01-15       Impact factor: 2.373

7.  Adaptive decision making in a lymphocyte infusion trial.

Authors:  Peter F Thall; Lurdes Y T Inoue; Thomas G Martin
Journal:  Biometrics       Date:  2002-09       Impact factor: 2.571

Review 8.  A group sequential, response-adaptive design for randomized clinical trials.

Authors:  Theodore G Karrison; Dezheng Huo; Rick Chappell
Journal:  Control Clin Trials       Date:  2003-10

9.  Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study.

Authors:  R H Bartlett; D W Roloff; R G Cornell; A F Andrews; P W Dillon; J B Zwischenberger
Journal:  Pediatrics       Date:  1985-10       Impact factor: 7.124

10.  A new design for randomized clinical trials.

Authors:  M Zelen
Journal:  N Engl J Med       Date:  1979-05-31       Impact factor: 91.245

View more
  59 in total

1.  Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity.

Authors:  Xiudong Lei; Ying Yuan; Guosheng Yin
Journal:  Lifetime Data Anal       Date:  2010-04-03       Impact factor: 1.588

2.  Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.

Authors:  Lorenzo Trippa; Eudocia Q Lee; Patrick Y Wen; Tracy T Batchelor; Timothy Cloughesy; Giovanni Parmigiani; Brian M Alexander
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

3.  Point-of-Care Clinical Trials in Sports Medicine Research: Identifying Effective Treatment Interventions Through Comparative Effectiveness Research.

Authors:  Kenneth C Lam; Cailee E Welch Bacon; Eric L Sauers; R Curtis Bay
Journal:  J Athl Train       Date:  2019-10-16       Impact factor: 2.860

4.  Optimal and lead-in adaptive allocation for binary outcomes: a comparison of Bayesian methodologies.

Authors:  Roy T Sabo; Ghalib Bello
Journal:  Commun Stat Theory Methods       Date:  2016-04-08       Impact factor: 0.893

5.  Do commonly used clinical trial designs reflect clinical reality?

Authors:  Elihu Estey
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

6.  Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials.

Authors:  Lorenzo Trippa; Patrick Y Wen; Giovanni Parmigiani; Donald A Berry; Brian M Alexander
Journal:  Neuro Oncol       Date:  2015-01-07       Impact factor: 12.300

7.  Adaptive clinical trial designs in oncology.

Authors:  Yong Zang; J Jack Lee
Journal:  Chin Clin Oncol       Date:  2014-12

8.  Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.

Authors:  P Thall; P Fox; J Wathen
Journal:  Ann Oncol       Date:  2015-05-15       Impact factor: 32.976

9.  Randomization and statistical power: paramount in trial reproducibility (even for rare cancers).

Authors:  Laurence H Baker; John J Crowley; Robert G Maki
Journal:  Oncologist       Date:  2012-08-22

10.  A Bayesian decision-theoretic sequential response-adaptive randomization design.

Authors:  Fei Jiang; J Jack Lee; Peter Müller
Journal:  Stat Med       Date:  2013-01-13       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.